Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells.

Willbold R, Wirth K, Martini T, Sültmann H, Bolenz C, Wittig R.

Cell Death Dis. 2019 Aug 9;10(8):601. doi: 10.1038/s41419-019-1830-8.

2.

Measuring Food Anticipation in Mice.

Martini T, Ripperger JA, Albrecht U.

Clocks Sleep. 2019 Mar;1(1):65-74. doi: 10.3390/clockssleep1010007.

3.

Systematic prostate biopsy still matters: A comprehensive analysis of MRI/TRUS-fusion targeted prostate biopsies across different indications.

Westhoff N, Baeßler B, von Hardenberg J, Hetjens S, Porubsky S, Siegel F, Martini T, Michel MS, Attenberger U, Ritter M.

Urol Oncol. 2019 Jul 30. pii: S1078-1439(19)30260-1. doi: 10.1016/j.urolonc.2019.07.004. [Epub ahead of print]

PMID:
31375340
4.

Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention.

Brilakis ES, Mashayekhi K, Tsuchikane E, Abi Rafeh N, Alaswad K, Araya M, Avran A, Azzalini L, Babunashvili AM, Bayani B, Bhindi R, Boudou N, Boukhris M, Božinović NŽ, Bryniarski L, Bufe A, Buller CE, Burke MN, Büttner HJ, Cardoso P, Carlino M, Christiansen EH, Colombo A, Croce K, Damas de Los Santos F, De Martini T, Dens J, Di Mario C, Dou K, Egred M, ElGuindy AM, Escaned J, Furkalo S, Gagnor A, Galassi AR, Garbo R, Ge J, Goel PK, Goktekin O, Grancini L, Grantham JA, Hanratty C, Harb S, Harding SA, Henriques JPS, Hill JM, Jaffer FA, Jang Y, Jussila R, Kalnins A, Kalyanasundaram A, Kandzari DE, Kao HL, Karmpaliotis D, Kassem HH, Knaapen P, Kornowski R, Krestyaninov O, Kumar AVG, Laanmets P, Lamelas P, Lee SW, Lefevre T, Li Y, Lim ST, Lo S, Lombardi W, McEntegart M, Munawar M, Navarro Lecaro JA, Ngo HM, Nicholson W, Olivecrona GK, Padilla L, Postu M, Quadros A, Quesada FH, Prakasa Rao VS, Reifart N, Saghatelyan M, Santiago R, Sianos G, Smith E, C Spratt J, Stone GW, Strange JW, Tammam K, Ungi I, Vo M, Vu VH, Walsh S, Werner GS, Wollmuth JR, Wu EB, Wyman RM, Xu B, Yamane M, Ybarra LF, Yeh RW, Zhang Q, Rinfret S.

Circulation. 2019 Jul 30;140(5):420-433. doi: 10.1161/CIRCULATIONAHA.119.039797. Epub 2019 Jul 29.

PMID:
31356129
5.

Erratum to 'Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy' [Urologic Oncology: Seminars and Original Investigations 36/12 (2018) 505-534].

Martini T, Heinkele J, Mayr R, Weis CA, Wezel F, Wahby S, Eckstein M, Schnöller T, Breyer J, Wirtz R, Ritter M, Bolenz C, Erben P.

Urol Oncol. 2019 Mar;37(3):227. doi: 10.1016/j.urolonc.2018.12.019. Epub 2018 Dec 27. No abstract available.

PMID:
30595464
6.

Proteomics of acquired pellicle in gastroesophageal reflux disease patients with or without erosive tooth wear.

Martini T, Rios D, Cassiano LPS, Silva CMS, Taira EA, Ventura TMS, Pereira HABS, Magalhães AC, Carvalho TS, Baumann T, Lussi A, Oliveira RB, Palma-Dibb RG, Buzalaf MAR.

J Dent. 2019 Feb;81:64-69. doi: 10.1016/j.jdent.2018.12.007. Epub 2018 Dec 21.

PMID:
30579861
7.

Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladder.

Erben P, Sikic D, Wirtz RM, Martini T, Weis CA, Breyer J, Otto W, Keck B, Hartmann A, Bolenz C; BRIDGE Consortium e.V.

Virchows Arch. 2019 Feb;474(2):209-217. doi: 10.1007/s00428-018-2496-9. Epub 2018 Nov 27.

PMID:
30483954
8.

Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.

Martini T, Heinkele J, Mayr R, Weis CA, Wezel F, Wahby S, Eckstein M, Schnöller T, Breyer J, Wirtz R, Ritter M, Bolenz C, Erben P.

Urol Oncol. 2018 Dec;36(12):530.e19-530.e27. doi: 10.1016/j.urolonc.2018.09.003. Epub 2018 Nov 13. Erratum in: Urol Oncol. 2019 Mar;37(3):227.

PMID:
30446441
9.

Mental health information online: what we have learned from social media metrics in BuzzFeed's Mental Health Week.

Martini T, Czepielewski LS, Baldez DP, Gliddon E, Kieling C, Berk L, Berk M, Kauer-Sant'Anna M.

Trends Psychiatry Psychother. 2018 Oct-Dec;40(4):326-336. doi: 10.1590/2237-6089-2018-0023. Epub 2018 Aug 23.

10.

Analysis of Polymorphisms in Genes Differentially Expressed in the Enamel of Mice with Different Genetic Susceptibilities to Dental Fluorosis.

Charone S, Küchler EC, Leite AL, Silva Fernandes M, Taioqui Pelá V, Martini T, Brondino BM, Magalhães AC, Dionisio TJ, F Santos C, Buzalaf MAR.

Caries Res. 2019;53(2):228-233. doi: 10.1159/000491554. Epub 2018 Aug 27.

PMID:
30149392
11.

Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation.

von Hardenberg J, Westhoff N, Baumunk D, Hausmann D, Martini T, Marx A, Porubsky S, Schostak M, Michel MS, Ritter M.

Urol Oncol. 2018 Sep;36(9):401.e1-401.e9. doi: 10.1016/j.urolonc.2018.05.022. Epub 2018 Aug 6.

PMID:
30093211
12.

Defining the target prior to prostate fusion biopsy: the effect of MRI reporting on cancer detection.

Westhoff N, Siegel F, Peter C, Hetjens S, Porubsky S, Martini T, von Hardenberg J, Michel MS, Budjan J, Ritter M.

World J Urol. 2019 Feb;37(2):327-335. doi: 10.1007/s00345-018-2400-x. Epub 2018 Jul 2.

PMID:
29967946
13.

Liver Proteome of Mice with Distinct Genetic Susceptibilities to Fluorosis Treated with Different Concentrations of F in the Drinking Water.

Khan ZN, Sabino IT, de Souza Melo CG, Martini T, da Silva Pereira HAB, Buzalaf MAR.

Biol Trace Elem Res. 2019 Jan;187(1):107-119. doi: 10.1007/s12011-018-1344-8. Epub 2018 Apr 29.

PMID:
29705835
14.

Changes in the Proteomic Profile of Acquired Enamel Pellicles as a Function of Their Time of Formation and Hydrochloric Acid Exposure.

Taira EA, Ventura TMS, Cassiano LPS, Silva CMS, Martini T, Leite AL, Rios D, Magalhães AC, Buzalaf MAR.

Caries Res. 2018;52(5):367-377. doi: 10.1159/000486969. Epub 2018 Mar 6.

PMID:
29510412
15.

Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer.

Mayr R, Gierth M, Zeman F, Reiffen M, Seeger P, Wezel F, Pycha A, Comploj E, Bonatti M, Ritter M, van Rhijn BWG, Burger M, Bolenz C, Fritsche HM, Martini T.

J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):505-513. doi: 10.1002/jcsm.12279. Epub 2018 Feb 25.

16.

Chronic effect of different types of stretching on ankle dorsiflexion range of motion: Systematic review and meta-analysis.

Medeiros DM, Martini TF.

Foot (Edinb). 2018 Mar;34:28-35. doi: 10.1016/j.foot.2017.09.006. Epub 2017 Oct 27. Review.

PMID:
29223884
17.

Interaction of PER2 with the Constitutive Androstane Receptor Possibly Links Circadian Rhythms to Metabolism.

Martini T, Stojan J, Rozman D, Prosenc Zmrzljak U.

Acta Chim Slov. 2017 Sep;64(3):571-576.

PMID:
28862300
18.

Prostate cancer detection among readers with different degree of experience using ultra-high b-value diffusion-weighted Imaging: Is a non-contrast protocol sufficient to detect significant cancer?

Hausmann D, Aksöz N, von Hardenberg J, Martini T, Westhoff N, Buettner S, Schoenberg SO, Riffel P.

Eur Radiol. 2018 Feb;28(2):869-876. doi: 10.1007/s00330-017-5004-8. Epub 2017 Aug 10.

PMID:
28799090
19.

[Role of the human ErbB family receptors in urothelial carcinoma of the bladder: mRNA expression status and prognostic relevance].

Erben P, Wezel F, Wirtz R, Martini T, Stein D, Weis CA, Hartmann A, Bolenz C.

Aktuelle Urol. 2017 Aug;48(4):356-362. doi: 10.1055/s-0043-110403. Epub 2017 Jul 27. German.

PMID:
28750448
20.

[Microscopic hematuria : Reasonable and risk-adapted diagnostic evaluation].

Löbig N, Wezel F, Martini T, Schröppel B, Bolenz C.

Urologe A. 2017 Sep;56(9):1139-1146. doi: 10.1007/s00120-017-0432-2. Review. German.

PMID:
28643107
21.

[Systematic review on conservative treatment options in non-muscle-invasive bladder cancer patients refractory to Bacillus Calmette-Guérin instillation therapy].

Martini T, Wezel F, Löbig N, Mitterberger MJ, Colleselli D.

Aktuelle Urol. 2017 Aug;48(4):314-328. doi: 10.1055/s-0043-108944. Epub 2017 Jun 13. German.

PMID:
28609792
22.

Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort.

Vetterlein MW, Meyer CP, Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, Keck B, Wullich B, Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian PJ, Gilfrich C, May M, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A; PROMETRICS 2011 study group.

Clin Genitourin Cancer. 2017 Oct;15(5):e809-e817. doi: 10.1016/j.clgc.2017.04.021. Epub 2017 Apr 26.

PMID:
28550955
23.

The Use of Neoadjuvant Chemotherapy in Patients With Urothelial Carcinoma of the Bladder: Current Practice Among Clinicians.

Martini T, Gilfrich C, Mayr R, Burger M, Pycha A, Aziz A, Gierth M, Stief CG, Müller SC, Wagenlehner F, Roigas J, Hakenberg OW, Roghmann F, Nuhn P, Wirth M, Novotny V, Hadaschik B, Grimm MO, Schramek P, Haferkamp A, Colleselli D, Kloss B, Herrmann E, Fisch M, May M, Bolenz C.

Clin Genitourin Cancer. 2017 Jun;15(3):356-362. doi: 10.1016/j.clgc.2016.09.003. Epub 2016 Sep 19.

PMID:
27765613
24.

Liver proteome of mice with different genetic susceptibilities to the effects of fluoride.

Khan ZN, Leite Ade L, Charone S, Sabino IT, Martini T, Pereira HA, Oliveira RC, Buzalaf MA.

J Appl Oral Sci. 2016 May-Jun;24(3):250-7. doi: 10.1590/1678-775720150364.

25.

Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.

Vallo S, Gilfrich C, Burger M, Volkmer B, Boehm K, Rink M, Chun FK, Roghmann F, Novotny V, Mani J, Brisuda A, Mayr R, Stredele R, Noldus J, Schnabel M, May M, Fritsche HM, Pycha A, Martini T, Wirth M, Roigas J, Bastian PJ, Nuhn P, Dahlem R, Haferkamp A, Fisch M, Aziz A.

Urol Oncol. 2016 Oct;34(10):432.e1-8. doi: 10.1016/j.urolonc.2016.05.008. Epub 2016 Jun 6.

PMID:
27283218
26.

Malignant Perivascular Epithelioid Cell Neoplasm (PEComa) of the Pelvis: A Case Report.

D'Andrea D, Hanspeter E, D'Elia C, Martini T, Pycha A.

Urol Case Rep. 2016 Mar 18;6:36-8. doi: 10.1016/j.eucr.2016.02.004. eCollection 2016 May.

27.

Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study.

Martini T, Aziz A, Roghmann F, Rink M, Chun FK, Fisch M, Trojan L, Hakenberg OW, Zastrow S, Wirth MP, Moersdorf J, Brookman-May S, Stief CG, Haferkamp A, Wagenlehner F, Hohenfellner M, Herrmann E, Lusuardi L, Grimm MO, Müller SC, Roigas J, Bastian PJ, Gierth M, Burger M, Pycha A, Seitz C, May M, Bolenz C.

Urol Int. 2016;96(1):57-64. doi: 10.1159/000433606. Epub 2015 Jul 1.

PMID:
26139354
28.

Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta.

Aziz A, Gierth M, Rink M, Schmid M, Chun FK, Dahlem R, Roghmann F, Palisaar RJ, Noldus J, Ellinger J, Müller SC, Pycha A, Martini T, Bolenz C, Moritz R, Herrmann E, Keck B, Wullich B, Mayr R, Fritsche HM, Burger M, Bastian PJ, Seitz C, Brookman-May S, Xylinas E, Shariat SF, Fisch M, May M; PROMETRICS 2011 Research Group.

World J Urol. 2015 Dec;33(12):1945-50. doi: 10.1007/s00345-015-1572-x. Epub 2015 May 7.

PMID:
25947885
29.

Impact of the use of bowel for urinary diversion on perioperative complications and 90-day mortality in patients aged 75 years or older.

Berger I, Wehrberger C, Ponholzer A, Wolfgang M, Martini T, Breinl E, Dunzinger M, Hofbauer J, Höltl W, Jeschke K, Krause SF, Kugler W, Rauchenwald M, Pauer W, Pycha A, Madersbacher S.

Urol Int. 2015;94(4):394-400. doi: 10.1159/000367853. Epub 2015 Jan 20.

PMID:
25612612
30.

[Detection of lymphovascular invasion in urothelial carcinoma of the bladder through D2-40 immunostaining].

Martini T, Ströbel P, Steidler A, Petrakopoulou N, Erben P, Bolenz C.

Urologe A. 2015 Jan;54(1):70-5. doi: 10.1007/s00120-014-3646-6. German.

PMID:
25391439
31.

Proteomic analysis of gastrocnemius muscle in rats with streptozotocin-induced diabetes and chronically exposed to fluoride.

Lima Leite A, Gualiume Vaz Madureira Lobo J, Barbosa da Silva Pereira HA, Silva Fernandes M, Martini T, Zucki F, Sumida DH, Rigalli A, Buzalaf MA.

PLoS One. 2014 Sep 2;9(9):e106646. doi: 10.1371/journal.pone.0106646. eCollection 2014.

32.

The Charlson comorbidity index predicts survival after disease recurrence in patients following radical cystectomy for urothelial carcinoma of the bladder.

Mayr R, May M, Burger M, Martini T, Pycha A, Dechet C, Lodde M, Comploj E, Wieland WF, Denzinger S, Otto W, Aziz A, Fritsche HM, Gierth M.

Urol Int. 2014;93(3):303-10. doi: 10.1159/000362421. Epub 2014 Aug 19.

PMID:
25139069
33.

IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status.

Worst TS, Reiner V, Gabriel U, Weiß C, Erben P, Martini T, Bolenz C.

Adv Urol. 2014;2014:184602. doi: 10.1155/2014/184602. Epub 2014 Jul 8.

34.

Perioperative complications and 90-day mortality of radical cystectomy in the elderly (75+): a retrospective, multicentre study.

Berger I, Martini T, Wehrberger C, Comploj E, Ponholzer A, Wolfgang M, Breinl E, Dunzinger M, Hofbauer J, Höltl W, Jeschke K, Krause S, Kugler W, Pauer W, Rauchenwald M, Pycha A, Madersbacher S.

Urol Int. 2014;93(3):296-302. doi: 10.1159/000357127. Epub 2014 Mar 15.

PMID:
24642400
35.

Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional study.

Ponholzer A, Trubel S, Schramek P, Wimpissinger F, Feichtinger H, Springer C, Wehrberger C, Fischereder K, Pummer K, Martini T, Mayr R, Pycha A, Madersbacher S.

World J Urol. 2014 Aug;32(4):911-6. doi: 10.1007/s00345-014-1252-2. Epub 2014 Feb 8.

PMID:
24510119
36.

Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.

Aziz A, May M, Burger M, Palisaar RJ, Trinh QD, Fritsche HM, Rink M, Chun F, Martini T, Bolenz C, Mayr R, Pycha A, Nuhn P, Stief C, Novotny V, Wirth M, Seitz C, Noldus J, Gilfrich C, Shariat SF, Brookman-May S, Bastian PJ, Denzinger S, Gierth M, Roghmann F; PROMETRICS 2011 research group.

Eur Urol. 2014 Jul;66(1):156-63. doi: 10.1016/j.eururo.2013.12.018. Epub 2013 Dec 27.

PMID:
24388438
37.

Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.

von Hardenberg J, Martini T, Knauer A, Ströbel P, Becker A, Herrmann E, Schubert C, Steidler A, Bolenz C.

Urol Oncol. 2014 Jan;32(1):54.e9-17. doi: 10.1016/j.urolonc.2013.08.031.

PMID:
24360666
38.

Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer.

Martini T, Mayr R, Wehrberger C, Dechet C, Lodde M, Palermo S, Trenti E, Comploj E, Pycha A, Madersbacher S.

Int Braz J Urol. 2013 Sep-Oct;39(5):622-30. doi: 10.1590/S1677-5538.IBJU.2013.05.03.

39.

Bipolar disorder affects behavior and social skills on the Internet.

Martini T, Czepielewski LS, Fijtman A, Sodré L, Wollenhaupt-Aguiar B, Pereira CS, Vianna-Sulzbach M, Goi PD, Rosa AR, Kapczinski F, Kunz M, Kauer-Sant'anna M.

PLoS One. 2013 Nov 11;8(11):e79673. doi: 10.1371/journal.pone.0079673. eCollection 2013.

40.

[Invasion patterns and metastasis of urothelial carcinoma. A challenge for translational research].

Bolenz C, Martini T, Michel MS.

Urologe A. 2013 Sep;52(9):1242-7. doi: 10.1007/s00120-013-3309-z. Review. German.

PMID:
23979445
41.

Validation of RiskCheck Bladder Cancer ©, version 5.0 for risk-adapted screening of bladder cancer.

Martini T, Mayr R, Lodde M, Seitz C, Trenti E, Comploj E, Palermo S, Pycha A, Mian C, Zywica M, Weidner W, Lüdecke G.

Urol Int. 2013;91(2):175-81. doi: 10.1159/000351036. Epub 2013 Jul 16.

PMID:
23860006
42.

Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?

Henning A, Wehrberger M, Madersbacher S, Pycha A, Martini T, Comploj E, Jeschke K, Tripolt C, Rauchenwald M.

BJU Int. 2013 Jul;112(1):68-73. doi: 10.1111/j.1464-410X.2012.11661.x. Epub 2013 Jan 15.

43.

Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy.

Lodde M, Mayr R, Martini T, Comploj E, Palermo S, Trenti E, Hanspeter E, Fritsche HM, Mian C, Pycha A.

World J Urol. 2012 Dec;30(6):841-6. doi: 10.1007/s00345-012-0975-1. Epub 2012 Nov 10.

PMID:
23143733
44.

Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer.

Cha EK, Tirsar LA, Schwentner C, Hennenlotter J, Christos PJ, Stenzl A, Mian C, Martini T, Pycha A, Shariat SF, Schmitz-Dräger BJ.

World J Urol. 2012 Dec;30(6):847-52. doi: 10.1007/s00345-012-0979-x. Epub 2012 Nov 5.

45.

Assessing the invasive potential of bladder cancer: development and validation of a new preclinical assay.

Bolenz C, Gorzelanny C, Knauf D, Keil T, Steidler A, Halter N, Martini T, Schneider SW.

J Urol. 2013 May;189(5):1939-44. doi: 10.1016/j.juro.2012.10.007. Epub 2012 Oct 11.

PMID:
23063805
46.

A comparison of hexaminolevulinate (Hexvix(®)) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study.

Lapini A, Minervini A, Masala A, Schips L, Pycha A, Cindolo L, Giannella R, Martini T, Vittori G, Zani D, Bellomo F, Cosciani Cunico S.

Surg Endosc. 2012 Dec;26(12):3634-41. doi: 10.1007/s00464-012-2387-0. Epub 2012 Jun 23.

PMID:
22729704
47.

Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder.

Mayr R, May M, Martini T, Lodde M, Comploj E, Pycha A, Strobel J, Denzinger S, Otto W, Wieland W, Burger M, Fritsche HM.

Eur Urol. 2012 Oct;62(4):662-70. doi: 10.1016/j.eururo.2012.03.057. Epub 2012 Apr 12.

PMID:
22534059
48.

Predictive capacity of four comorbidity indices estimating perioperative mortality after radical cystectomy for urothelial carcinoma of the bladder.

Mayr R, May M, Martini T, Lodde M, Pycha A, Comploj E, Wieland WF, Denzinger S, Otto W, Burger M, Fritsche HM.

BJU Int. 2012 Sep;110(6 Pt B):E222-7. doi: 10.1111/j.1464-410X.2012.10938.x. Epub 2012 Feb 7.

49.

Back-scattered electron imaging for leakage analysis of four retrofilling materials.

Chittoni SB, Martini T, Wagner MH, Da Rosa RA, Cavenago BC, Duarte MA, Klein CA Jr, Só MV.

Microsc Res Tech. 2012 Jun;75(6):796-800. doi: 10.1002/jemt.21128. Epub 2011 Dec 6.

PMID:
22147679
50.

Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre study.

Cha EK, Tirsar LA, Schwentner C, Christos PJ, Mian C, Hennenlotter J, Martini T, Stenzl A, Pycha A, Shariat SF, Schmitz-Dräger BJ.

Eur Urol. 2012 Jan;61(1):185-92. doi: 10.1016/j.eururo.2011.08.073. Epub 2011 Sep 9.

Supplemental Content

Loading ...
Support Center